Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,526 public trials 2,840 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Study of Liposomal Annamycin in Combination With Cytarabine for the Treatment of Subjects With Acute Myeloid Leukemia (AML)

NCT05319587

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Istituto Scientifico Romagolo per lo studio dei umori "Dino Amadori" (IRST) - IRCCS Meldola, FC, Italy
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
  • Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, Italy
  • Uniwersytecki Szpital Kliniczny Klinika Hematologii Nowotworow Wroclaw, Dolnośląskie Województwo, Poland
View Trial Details
Completed

A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL

NCT04984356

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • City of Hope Duarte, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Completed

A Phase 1 Study of WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)

NCT05470140

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Healthcare Palo Alto, California, United States
  • Norton Health Care Louisville, Kentucky, United States
  • University of Maryland Baltimore, Maryland, United States
View Trial Details
Completed

A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

NCT03069352

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • H. Lee Moffit Cancer Center /ID# 164273 Tampa, Florida, United States
  • Norton Cancer Institute /ID# 158998 Louisville, Kentucky, United States
  • Univ of Pittsburgh Med Ctr /ID# 158997 Pittsburgh, Pennsylvania, United States
  • Univ TX, MD Anderson /ID# 159678 Houston, Texas, United States
View all 109 locations
View Trial Details
Completed

A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A

NCT03061201

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • City of Hope Medical Center Duarte, California, United States
  • Midtown Ambulatory Care Center Sacramento, California, United States
  • UC Davis Ambulatory Care Clinic Sacramento, California, United States
View all 22 locations
View Trial Details
Completed

Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma

NCT03731832

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Klinikum rechts der Isar der TU München / III. Med. Klinik und Poliklinik Munich, Bavaria, Germany
  • phase drei Hämato-Onkologischer Studienkreis am Klinikum Aschaffenburg Aschaffenburg, Germany
  • Sozialstiftung Bamberg / Klinik am Bruderwald, Zentrum für Innere Medizin, Med. Klinik V, Hämatologie und internistische Onkologie Bamberg, Germany
  • Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main Frankfurt am Main, Germany
View Trial Details

Related conditions